A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag

PHASE2TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

April 19, 2023

Study Completion Date

April 19, 2023

Conditions
Sarcoidosis-associated Pulmonary Hypertension
Interventions
DRUG

Selexipag

Oral tablets containing 200 µg of selexipag. Depending on the iMTD, participants will receive 1 (200 µg) to 8 (1600 µg) tablets at each administration

DRUG

Placebo

Oral tablets without active compound. Participants can receive 1 to 8 tablets at each administration.

Trial Locations (38)

3000

Universitaire Ziekenhuizen Leuven, Leuven

10029

Icahn School of Medicine at Mount Sinai, New York

10126

A.O.U. Città della Salute e della Scienza, Torino

13125

Evangelische Lungenklinik Berlin, Berlin

13915

Hopital Nord, Marseille

20123

Ospedale S.Giuseppe, Gruppo MultiMedica, Milan

23538

Universitatsklinikum Schleswig Holstein, Lübeck

27100

Fondazione Maugeri Montescano, Pavia

27514

University of North Carolina at Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

39008

Hosp. Univ. Marques de Valdecilla, Santander

45267

University of Cincinnati, Cincinnati

46260

St. Vincent Medical Group, Inc., Indianapolis

53105

Universitatsklinikum Bonn, Bonn

54511

CHU de Nancy - Hopital de Brabois, Vandœuvre-lès-Nancy

69126

Thoraxklinik Heidelberg, Heidelberg

69677

GH est - Hôpital Cardiovasculaire et Pneumologie Louis Pradel, Bron

70112

LSU Health Sciences Center New Orleans, New Orleans

70839

RBK Lungenzentrum Stuttgart am Robert-Bosch-Krankenhaus, Stuttgart

93000

Hôpital Avicenne, Bobigny

93053

Universitaetsklinikum Regensburg, Regensburg

94270

Hôpital Kremlin Bicêtre, Le Kremlin-Bicêtre

97074

Klinikum Würzburg Mitte gGmbH Standort Missioklinik, Würzburg

44195-0001

Cleveland Clinic, Cleveland

29425-8900

Medical University of South Carolina (MUSC) - College of Medicine (COM), Charleston

60840-285

Secretaria da Saude do Estado do Ceara - Hospital Doutor Carlos Alberto Studart Gomes, Fortaleza

90035-903

Hospital das Clinicas de Porto Alegre, Porto Alegre

05403-000

Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo

N6A 5W9

London Health Sciences Centre, London

H3T 1E2

Jewish General Hospital, Montreal

01307

Universitatsklinikum Carl Gustav Carcus Dresden, Dresden

00165

Umberto I Pol. di Roma-Università di Roma La Sapienza, Roma

00168

Universita Cattolica del Sacro Cuore - Fondazione Policlinico Universitario 'A. Gemelli', Roma

1081 HV

VUMC Amsterdam, Amsterdam

3435 CM

Sint Antonius Ziekenhuis, Nieuwegein

08036

Hosp. Clinic de Barcelona, Barcelona

NW3 2QG

Royal Free Hospital, London

SW3 6NP

Royal Brompton Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY

NCT03942211 - A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag | Biotech Hunter | Biotech Hunter